Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.

Identifieur interne : 000443 ( PubMed/Curation ); précédent : 000442; suivant : 000444

Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.

Auteurs : Jeong Yoon Lee [Corée du Sud] ; Sojung Bae [Corée du Sud] ; Jinjong Myoung [Corée du Sud]

Source :

RBID : pubmed:31452044

Descripteurs français

English descriptors

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is a causative agent of severe-to-fatal pneumonia especially in patients with pre-existing conditions, such as smoking and chronic obstructive pulmonary disease (COPD). MERS-CoV transmission continues to be reported in the Saudi Arabian Peninsula since its discovery in 2012. However, it has rarely been epidemic outside the area except one large outbreak in South Korea in May 2015. The genome of the epidemic MERS-CoV isolated from a Korean patient revealed its homology to previously reported strains. MERS-CoV encodes 5 accessory proteins and generally, they do not participate in the genome transcription and replication but rather are involved in viral evasion of the host innate immune responses. Here we report that ORF8b, an accessory protein of MERS-CoV, strongly inhibits both MDA5- and RIG-I-mediated activation of interferon beta promoter activity while downstream signaling molecules were left largely unaffected. Of note, MDA5 protein levels were significantly down-regulated by ORF8b and co-expression of ORF4a and ORF4b. These novel findings will facilitate elucidation of mechanisms of virus-encoded evasion strategies, thus helping design rationale antiviral countermeasures against deadly MERS-CoV infection.

DOI: 10.1007/s12275-019-9272-7
PubMed: 31452044

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31452044

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.</title>
<author>
<name sortKey="Lee, Jeong Yoon" sort="Lee, Jeong Yoon" uniqKey="Lee J" first="Jeong Yoon" last="Lee">Jeong Yoon Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bae, Sojung" sort="Bae, Sojung" uniqKey="Bae S" first="Sojung" last="Bae">Sojung Bae</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Myoung, Jinjong" sort="Myoung, Jinjong" uniqKey="Myoung J" first="Jinjong" last="Myoung">Jinjong Myoung</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea. Jinjong.myoung@jbnu.ac.kr.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31452044</idno>
<idno type="pmid">31452044</idno>
<idno type="doi">10.1007/s12275-019-9272-7</idno>
<idno type="wicri:Area/PubMed/Corpus">000443</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000443</idno>
<idno type="wicri:Area/PubMed/Curation">000443</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000443</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.</title>
<author>
<name sortKey="Lee, Jeong Yoon" sort="Lee, Jeong Yoon" uniqKey="Lee J" first="Jeong Yoon" last="Lee">Jeong Yoon Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bae, Sojung" sort="Bae, Sojung" uniqKey="Bae S" first="Sojung" last="Bae">Sojung Bae</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Myoung, Jinjong" sort="Myoung, Jinjong" uniqKey="Myoung J" first="Jinjong" last="Myoung">Jinjong Myoung</name>
<affiliation wicri:level="1">
<nlm:affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea. Jinjong.myoung@jbnu.ac.kr.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of microbiology (Seoul, Korea)</title>
<idno type="eISSN">1976-3794</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Coronavirus Infections (genetics)</term>
<term>Coronavirus Infections (metabolism)</term>
<term>Coronavirus Infections (virology)</term>
<term>DEAD Box Protein 58 (genetics)</term>
<term>DEAD Box Protein 58 (metabolism)</term>
<term>Drug Design</term>
<term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>Interferon-Induced Helicase, IFIH1 (genetics)</term>
<term>Interferon-Induced Helicase, IFIH1 (metabolism)</term>
<term>Interferon-beta (genetics)</term>
<term>Interferon-beta (metabolism)</term>
<term>Middle East Respiratory Syndrome Coronavirus (genetics)</term>
<term>Middle East Respiratory Syndrome Coronavirus (metabolism)</term>
<term>Promoter Regions, Genetic</term>
<term>Saudi Arabia</term>
<term>Viral Vaccines (genetics)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Arabie saoudite</term>
<term>Conception de médicament</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (génétique)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (métabolisme)</term>
<term>Humains</term>
<term>Hélicase IFIH1 inductrice de l'interféron (génétique)</term>
<term>Hélicase IFIH1 inductrice de l'interféron (métabolisme)</term>
<term>Infections à coronavirus (génétique)</term>
<term>Infections à coronavirus (métabolisme)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Interactions hôte-pathogène</term>
<term>Interféron bêta (génétique)</term>
<term>Interféron bêta (métabolisme)</term>
<term>Protéine-58 à domaine DEAD (génétique)</term>
<term>Protéine-58 à domaine DEAD (métabolisme)</term>
<term>Régions promotrices (génétique)</term>
<term>Vaccins antiviraux (génétique)</term>
<term>Vaccins antiviraux (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DEAD Box Protein 58</term>
<term>Interferon-Induced Helicase, IFIH1</term>
<term>Interferon-beta</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Saudi Arabia</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Hélicase IFIH1 inductrice de l'interféron</term>
<term>Infections à coronavirus</term>
<term>Interféron bêta</term>
<term>Protéine-58 à domaine DEAD</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Coronavirus Infections</term>
<term>DEAD Box Protein 58</term>
<term>Interferon-Induced Helicase, IFIH1</term>
<term>Interferon-beta</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Hélicase IFIH1 inductrice de l'interféron</term>
<term>Infections à coronavirus</term>
<term>Interféron bêta</term>
<term>Protéine-58 à domaine DEAD</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Design</term>
<term>Host-Pathogen Interactions</term>
<term>Humans</term>
<term>Promoter Regions, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Arabie saoudite</term>
<term>Conception de médicament</term>
<term>Humains</term>
<term>Interactions hôte-pathogène</term>
<term>Régions promotrices (génétique)</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Arabie saoudite</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) is a causative agent of severe-to-fatal pneumonia especially in patients with pre-existing conditions, such as smoking and chronic obstructive pulmonary disease (COPD). MERS-CoV transmission continues to be reported in the Saudi Arabian Peninsula since its discovery in 2012. However, it has rarely been epidemic outside the area except one large outbreak in South Korea in May 2015. The genome of the epidemic MERS-CoV isolated from a Korean patient revealed its homology to previously reported strains. MERS-CoV encodes 5 accessory proteins and generally, they do not participate in the genome transcription and replication but rather are involved in viral evasion of the host innate immune responses. Here we report that ORF8b, an accessory protein of MERS-CoV, strongly inhibits both MDA5- and RIG-I-mediated activation of interferon beta promoter activity while downstream signaling molecules were left largely unaffected. Of note, MDA5 protein levels were significantly down-regulated by ORF8b and co-expression of ORF4a and ORF4b. These novel findings will facilitate elucidation of mechanisms of virus-encoded evasion strategies, thus helping design rationale antiviral countermeasures against deadly MERS-CoV infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31452044</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>08</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1976-3794</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>57</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2019</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of microbiology (Seoul, Korea)</Title>
<ISOAbbreviation>J. Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.</ArticleTitle>
<Pagination>
<MedlinePgn>803-811</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s12275-019-9272-7</ELocationID>
<Abstract>
<AbstractText>Middle East respiratory syndrome coronavirus (MERS-CoV) is a causative agent of severe-to-fatal pneumonia especially in patients with pre-existing conditions, such as smoking and chronic obstructive pulmonary disease (COPD). MERS-CoV transmission continues to be reported in the Saudi Arabian Peninsula since its discovery in 2012. However, it has rarely been epidemic outside the area except one large outbreak in South Korea in May 2015. The genome of the epidemic MERS-CoV isolated from a Korean patient revealed its homology to previously reported strains. MERS-CoV encodes 5 accessory proteins and generally, they do not participate in the genome transcription and replication but rather are involved in viral evasion of the host innate immune responses. Here we report that ORF8b, an accessory protein of MERS-CoV, strongly inhibits both MDA5- and RIG-I-mediated activation of interferon beta promoter activity while downstream signaling molecules were left largely unaffected. Of note, MDA5 protein levels were significantly down-regulated by ORF8b and co-expression of ORF4a and ORF4b. These novel findings will facilitate elucidation of mechanisms of virus-encoded evasion strategies, thus helping design rationale antiviral countermeasures against deadly MERS-CoV infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jeong Yoon</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bae</LastName>
<ForeName>Sojung</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Myoung</LastName>
<ForeName>Jinjong</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Korea Zoonosis Research Institute, Genetic Engineering Research Institute & Department of Bioactive Material Science, College of Natural Science, Chonbuk National University, Jeonju, 54531, Republic of Korea. Jinjong.myoung@jbnu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>08</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Korea (South)</Country>
<MedlineTA>J Microbiol</MedlineTA>
<NlmUniqueID>9703165</NlmUniqueID>
<ISSNLinking>1225-8873</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>77238-31-4</RegistryNumber>
<NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="C452820">DDX58 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.4.13</RegistryNumber>
<NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.4.13</RegistryNumber>
<NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011401" MajorTopicYN="Y">Promoter Regions, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MERS-CoV</Keyword>
<Keyword MajorTopicYN="N">ORF8b</Keyword>
<Keyword MajorTopicYN="N">accessory protein</Keyword>
<Keyword MajorTopicYN="N">interferon beta</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>06</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>06</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2019</Year>
<Month>06</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31452044</ArticleId>
<ArticleId IdType="doi">10.1007/s12275-019-9272-7</ArticleId>
<ArticleId IdType="pii">10.1007/s12275-019-9272-7</ArticleId>
<ArticleId IdType="pmc">PMC7091237</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2002 Apr;76(8):3697-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11907209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Jun;76(11):5532-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11991981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2003 May;4(5):491-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12692549</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1965 Jun 5;1(5448):1467-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14288084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Apr;10(4):368-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15034574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jan;79(2):884-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15613317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2005 Sep 9;122(5):669-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16125763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2005 Oct;6(10):981-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16127453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Oct 20;437(7062):1167-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16177806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2005 Dec 1;192(11):1898-907</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16267760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2006 Mar 1;42(5):634-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16447108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2006 Feb 24;124(4):783-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16497588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 May;80(10):5059-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16641297</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Jun;80(11):5168-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16698997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2006 Jun;44(6):2063-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16757599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2006 Sep;6(9):644-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16932750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2006 Sep;25(3):349-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16979567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci STKE. 2006 Oct 17;2006(357):re13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17047224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jan;81(2):568-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17079305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2007 Apr 25;361(1):18-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17316733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2007 Aug 16;448(7155):816-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17653195</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2007 Oct 26;282(43):31131-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17823124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2007 Oct 18;449(7164):819-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17943118</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 2008 Apr;33(4):171-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18353649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Apr;83(7):3069-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19153231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2008 Sep;18(9):889-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19160540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Genet Evol. 2009 Dec;9(6):1185-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19800030</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Mar;84(6):3004-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20071589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Open Virol J. 2010 May 25;4:76-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20700397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2011 Feb;12(2):137-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21217758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2118-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21245317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2011 Apr 21;9(4):299-309</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21501829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Appl Environ Microbiol. 2012 Aug;78(15):5440-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22610439</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2012 Sep 27;17(39):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23041020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2012 Nov 20;3(6):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2013 Feb 8;339(6120):690-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23328395</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 May;87(9):5300-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23449793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Nov;87(22):12489-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24027320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Dec;87(24):13141-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24067967</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Cell. 2013 Dec;4(12):951-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24318862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2014 Apr;95(Pt 4):874-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24443473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 May;88(9):4866-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24522921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2014 Apr 17;10(4):e1004081</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24743923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2014 May 29;10(5):e1004166</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24874215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 Oct 16;514(7522):372-375</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25119032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2015 Jan;235(2):175-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25294366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2015 Mar 13;347(6227):aaa2630</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25636800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Methods Mol Biol. 2015;1282:1-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25720466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25810418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Health. 2015 Jul 21;37:e2015033</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26212508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Announc. 2015 Aug 13;3(4):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26272558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trans R Soc Trop Med Hyg. 2015 Sep;109(9):541-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26286944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med. 2015 Sep 03;13:210</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26336062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2015 Dec;96(12):3635-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26467721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2016 Jan;186(1):78-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26597880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2015 Nov 25;90(3):1557-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26608320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2015 Dec 03;5:17554</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26631542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Western Pac Surveill Response J. 2015 Aug 07;6(3):1-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26668758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2016 Jan;22(1):49-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26692185</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Health. 2015 Nov 14;37:e2015049</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26725226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2016 Apr;161(4):779-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26780772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2016 Jun 01;13(1):133</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27250711</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Chemother. 2016 Jun;48(2):145-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27433388</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Virol. 2016 Sep 29;3(1):77-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27578437</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Virus Res. 2016;96:219-243</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27712625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hosp Infect. 2017 Feb;95(2):207-213</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28153558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Infect Dis. 2017 May;58:37-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28223175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol. 2017 May;55(5):319-329</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28455586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2017 Jun 12;546(7658):340</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28617480</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 Sep 1;199(5):1846-1855</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28760879</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biotechniques. 2017 Sep 1;63(3):125-130</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28911316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Biotechnol. 2017 Oct 28;27(10):1727-1735</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29017236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2018 Jan 6;66(1):45-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29020176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>F1000Res. 2017 Sep 1;6:1628</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29026532</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FASEB J. 2018 Aug;32(8):4380-4393</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29513570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2018 Apr;556(7700):255-258</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29618817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>mSphere. 2018 Jun 20;3(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29925671</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Biotechnol. 2018 Sep 28;28(9):1554-1562</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30199924</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Biotechnol. 2018 Nov 28;28(11):1908-1915</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30304915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2019 Feb 13;11(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30781790</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2019 Feb 20;9(1):2372</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30787356</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2019 Mar 19;11(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30893947</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2019 Mar 26;10(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30914508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Soc Exp Biol Med. 1966 Jan;121(1):190-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4285768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1967 Sep 23;3(5568):767-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6043624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000443 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000443 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:31452044
   |texte=   Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:31452044" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021